Canadian investors could consider owning beaten-down AI stocks such as AMD to generate outsized gains in the next 12 months.

Imagine if you could multiply your workforce without adding a single new hire. What if your team could focus on creative, ...

UiPath, a leading enterprise automation and AI software company, has announced its annual UiPath Agentic AI Summit will take ...

UiPath to hold Agentic AI Summit on March 25 to demonstrate its latest agentic automation innovations and how UiPath ...

Cathie Wood’s ARK ETFs made some significant trades on Tuesday, including selling of Meta Platforms’ (META) stock, while boosting its ...

In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...

Zurcher Kantonalbank Zurich Cantonalbank grew its stake in UiPath Inc. (NYSE:PATH – Free Report) by 57.5% in the 4th quarter, ...

Steward Partners Investment Advisory LLC grew its position in shares of UiPath Inc. (NYSE:PATH – Free Report) by 99.8% during ...

UiPath (PATH) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

UiPath (PATH) has seen its stock hit an all-time low following a bleak revenue forecast issued as a part of its Q4 FY 2025 financial results.

ARK also bought 79,201 shares of IBOTTA INC (NASDAQ:IBTA) across its ARKW and ARKF ETFs, with a total value of approximately $3.17 million. Notably, this purchase adds to ARK’s ongoing accumulation of ...

UiPath (NYSE:PATH) saw its stock plummet over 14% intra-day today after delivering a disappointing revenue forecast for ...